| Zhang, Lili |
NCT04373967: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes |
|
|
| Recruiting | 3 | 424 | RoW | Victoza®., Metformin Hydrochloride, TQZ2451 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Type 2 Diabetes | 12/21 | 12/21 | | |
| Completed | 3 | 533 | RoW | Chiglitazar 32mg, Bilessglu, CS038, Chiglitazar 48mg, Placebo, Chiglitazar simulator, Metformin Hydrochloride, Glucophage | Chipscreen Biosciences, Ltd. | Type 2 Diabetes | 02/23 | 02/23 | | |
TORCHLIGHT, NCT04085276: Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment |
|
|
| Active, not recruiting | 3 | 531 | RoW | JS001, Nab-Paclitaxel, Placebo | Shanghai Junshi Bioscience Co., Ltd. | Triple-Negative Breast Cancer | 12/24 | 12/25 | | |
NCT05433480: A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer |
|
|
| Active, not recruiting | 3 | 274 | RoW | BPI-16350, placebo, Fulvestrant | Betta Pharmaceuticals Co., Ltd. | Breast Cancer | 12/23 | 07/25 | | |
NCT06633783: A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy® |
|
|
| Not yet recruiting | 3 | 370 | RoW | Semaglutide | Hangzhou Jiuyuan Gene Engineering Co. Ltd., | Obesity | 05/26 | 10/26 | | |
NCT05375123: Reference Range for Tissue Motion Tracking of Mitral Annulus Displacement in Chinese Han Singleton Pregnancies |
|
|
| Recruiting | N/A | 660 | RoW | Ultrasound image acquisition | First Hospital of China Medical University | Pregnancy | 06/23 | 06/24 | | |
NCT05547841: Normal Reference Value for Echocardiography in Chinese Han Pregnancies |
|
|
| Recruiting | N/A | 680 | RoW | Echocardiography acquisition | First Hospital of China Medical University | Pregnancy | 08/23 | 08/24 | | |
NCT06166082: Stanford Neuromodulation Therapy (SNT) for the Treatment-Resistant Depression |
|
|
| Recruiting | N/A | 130 | RoW | Active iTBS-DLPFC, Sham iTBS-DLPFC | Changping Laboratory, Xianyue Hospital, Xiamen, Hebei Mental Health Center, Baoding, HuiLongGuan Hospital, Beijing, Wuhan Mental Health Center, Wuhan, Zhumadian Second People's Hospital, Zhumadian | Treatment Resistant Depression | 07/24 | 10/24 | | |
NCT06350396: pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression |
|
|
| Recruiting | N/A | 270 | RoW | active rTMS treatment, sham rTMS treatment | Changping Laboratory | Treatment Resistant Depression, Major Depressive Disorder | 12/24 | 06/25 | | |
NCT05855395: The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19 |
|
|
| Recruiting | N/A | 5815 | RoW | Glucocorticoid, dexamethasone, prednisone, methylprednisolone | Huashan Hospital | COVID-19 | 05/24 | 12/24 | | |
